Knut Tore Lappegård
Bjørn Ove Faldaas,
Erik Waage Nielsen,
Benjamin Stage Storm,
Knut Tore Lappegård,
Bent Aksel Nilsen,
Gabriel Hanssen Kiss
et al.:
Real-time feedback on chest compression efficacy by hands-free carotid Doppler in a porcine model
Bjørn Ove Faldaas,
Benjamin Stage Storm,
Knut Tore Lappegård,
Ole-Jakob How,
Bent Aksel Nilsen,
Gabriel Hanssen Kiss
et al.:
A hands-free carotid Doppler can identify spontaneous circulation without interrupting cardiopulmonary resuscitation: an animal study
Sajan Raju,
Antonio Molinaro,
Ayodeji Olawale Awoyemi,
Silje Fjellgård Jørgensen,
Peder Rustøen Braadland,
Andraz Nendl
et al.:
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Anette Krane,
Gunn Pettersen,
Knut Tore Lappegård,
Tove Aminda Hanssen
:
In need of percutaneous coronary intervention in an arctic setting– patients’ experience of safety and quality of care: a qualitative study
Liv Nesse Hande,
Hilde Thunhaug,
Judith K Ludviksen,
Anders Wilhelm Hovland,
Knut Tore Lappegård
:
No effect of omega-3 polyunsaturated fatty acid supplementation on inflammatory markers in familial hypercholesterolemia: a randomized crossover trial
Bjørn Ove Faldaas,
Erik Waage Nielsen,
Benjamin Storm,
Knut Tore Lappegård,
Ole-Jakob How,
Bent Aksel Nilsen
et al.:
Hands-free continuous carotid Doppler ultrasound for detection of the pulse during cardiac arrest in a porcine model
Andraz Nendl,
Sajan Raju,
Kaspar Broch,
Christiane Caroline Mayerhofer,
Kristian Holm,
Bente Halvorsen
et al.:
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
Liv Nesse Hande,
Christian Abendstein Kjellmo,
Kristin Pettersen,
Stefan Ljunggren,
Helen Karlsson,
Karin Cederbrant
et al.:
Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia: A Randomized Crossover Trial
Christopher Storm Larsen,
Liv Nesse Hande,
Martin Kummen,
Hilde Thunhaug,
Beate Vestad,
Simen Hyll Hansen
et al.:
Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention–a pilot trial
Amalie Nilsen Hagen,
Inger Kristine Holtermann Ariansen,
Tove Aminda Hanssen,
Knut Tore Lappegård,
Anne Elise Eggen,
Maja-Lisa Løchen
et al.:
Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study
Britta Susanne Bürker,
Randolf Inge Hardersen,
Knut Tore Lappegård
:
Symptoms of Depression, Anxiety, and Posttraumatic Stress among Patients with Cardiac Pacemakers
Kristina Barbara Slåtsve,
Tor Claudi,
Knut Tore Lappegård,
Anne Karen Jenum,
Marthe Larsen,
Kjersti Nøkleby
et al.:
Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study
Ingrid Petrikke Olsen,
Børge Lillebo,
Eirik Hugaas Ofstad,
Arve Østlyngen,
Knut Tore Lappegård
:
Tid for å utdanne flere leger desentralt
Tidsskrift for Den norske legeforening (Tidsskriftet) 2021 DOI
Amalie Nilsen,
Tove Aminda Hanssen,
Knut Tore Lappegård,
Anne Elise Eggen,
Maja-Lisa Løchen,
Randi Marie Selmer
et al.:
Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: The Tromsø Study 2015-2016
Kristina Barbara Slåtsve,
Tor Claudi,
Knut Tore Lappegård,
Anne Karen Jenum,
Marthe Larsen,
Kjersti Nøkleby
et al.:
Factors associated with treatment in primary versus specialist care: A population-based study of people with type 2 and type 1 diabetes
Knut Tore Lappegård,
Christian Kjellmo,
Anders Hovland
:
High-density lipoprotein subfractions: Much ado about nothing or clinically important?
Ayodeji Olawale Awoyemi,
Christiane Caroline Mayerhofer,
Alex S. Felix,
Johannes Espolin Roksund Hov,
Samuel D. Moscavitch,
Knut Tore Lappegård
et al.:
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
Knut Tore Lappegård,
Frode Moe
:
Remote Monitoring of CIEDs—For Both Safety, Economy and Convenience?
Remedios López-Liria,
Antonio López-Villegas,
César Leal-Costa,
Salvador Peiró,
Emilio Robles-Musso,
Rafael Bautista-Mesa
et al.:
Effectiveness and safety in remote monitoring of patients with pacemakers five years after an implant: The Poniente study
Daniel Catalán-Matamoros,
Antonio Lopez-Villegas,
Knut Tore Lappegård,
Remedios Lopez-Liria
:
Assessing communication during remote follow-up of users with pacemakers in Norway: The Nordland study, a randomized trial
Anders Hovland,
Kjetil Retterstøl,
Tom Eirik Mollnes,
Bente Evy Halvorsen,
Pål Aukrust,
Knut Tore Lappegård
:
Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?
Leal-Costa Cesar,
Antonio Lopez-Villegas,
Daniel Catalan-Matamoros,
Emilio Robles-Musso,
Knut Tore Lappegård,
Bautista-Mesa Rafael Jesus
et al.:
Long-Term Socioeconomic Impact of Informal Care Provided to Patients with Pacemakers: Remote vs. Conventional Monitoring
Antonio Lopez-Villegas,
Daniel Catalán-Matamoros,
Salvador Peiró,
Knut Tore Lappegård,
Remedios Lopez-Liria
:
Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial
Kristina Barbara Slåtsve,
Tor Claudi,
Knut Tore Lappegård,
Anne Karen Jenum,
Marthe Larsen,
John Cooper
et al.:
The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, Norway
Remedios Lopez-Liria,
Antonio Lopez-Villegas,
Terje Enebakk,
Hilde Thunhaug,
Knut Tore Lappegård,
Daniel Catalán-Matamoros
:
Telemonitoring and quality of life in patients after 12 months following a pacemaker implant: The Nordland study, a randomised trial
Randolf Inge Hardersen,
Terje Enebakk,
Dorte Christiansen,
Judith K Ludviksen,
Tom Eirik Mollnes,
Knut Tore Lappegård
et al.:
Comparison of cytokine changes in three different lipoprotein apheresis systems in an ex vivo whole blood model
Amalie Nilsen,
Tove Aminda Hanssen,
Knut Tore Lappegård,
Anne Elise Eggen,
Maja-Lisa Løchen,
Inger Njølstad
et al.:
Secular and longitudinal trends in cardiovascular risk in a general population using a national risk model: The Tromsø Study
European Journal of Preventive Cardiology (EJPC) 2019 DOI
Daniel Catalán-Matamoros,
Antonio Lopez-Villegas,
Knut Tore Lappegård,
Remedios Lopez-Liria
:
Patients' experiences of remote communication after pacemaker implant: The NORDLAND study
Liv Nesse Hande,
Hilde Thunhaug,
Terje Enebakk,
Judith K Ludviksen,
Kristin Pettersen,
Anders Hovland
et al.:
Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function
Christiane Caroline Mayerhofer,
Ayodeji Olawale Awoyemi,
Samuel D. Moscavitch,
Knut Tore Lappegård,
Johannes Espolin Roksund Hov,
Pål Aukrust
et al.:
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
Randolf Inge Hardersen,
Terje Enebakk,
Dorte Christiansen,
Grete Bergseth,
Ole-Lars Brekke,
Tom Eirik Mollnes
et al.:
Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) ? an ex vivo study with blood from a C5-deficient individual
Antonio Lopez-Villegas,
Daniel Catalán-Matamoros,
Remedios Lopez-Liria,
Terje Enebakk,
Hilde Thunhaug,
Knut Tore Lappegård
:
Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial
Christian Kjellmo,
Anders Hovland,
Knut Tore Lappegård
:
CVD Risk Stratification in the PCSK9 Era: Is There a
Role for LDL Subfractions?
Diseases 2018 DOI
Anne Landsem,
Hilde Fure,
Judith K Ludviksen,
Dorte Christiansen,
Corinna Lau,
Monica Dammen Mathisen
et al.:
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.
Knut Tore Lappegård,
Christian Kjellmo,
Stefan Ljunggren,
Karin Cederbrant,
Maritha Marcusson-Ståhl,
Monica Dammen Mathisen
et al.:
Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot study
Transfusion and Apheresis Science 2018 DOI
Christian Kjellmo,
Helen Karlsson,
Torunn Kristin Nestvold,
Stefan Ljunggren,
Karin Cederbrant,
Maritha Marcusson-Ståhl
et al.:
Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity
Journal of Clinical Lipidology 2018 DOI
Anders Hovland,
Torunn Kristin Nestvold,
Pavol Bohov,
Marius Trøseid,
Pål Aukrust,
Rolf Kristian Berge
et al.:
Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Silje Bergland Ellingsen,
Elisabet N Nordmo,
Knut Tore Lappegård
:
Recurrence and severe worsening of hepatotoxicity after reintroduction of atorvastatin in combination with ezetimibe
Clinical Medicine Insights: Case Reports 2017 DOI
Knut Tore Lappegård,
Terje Enebakk,
Hilde Thunhaug,
Judith K Ludviksen,
Tom Eirik Mollnes,
Anders Hovland
:
LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response
Journal of Clinical Lipidology 2016 DOI
Marius Trøseid,
Johannes Espolin Roksund Hov,
Torunn Kristin Nestvold,
Hanne Thoresen,
Rolf Kristian Berge,
Asbjørn M. Svardal
et al.:
Major increase in microbiota-dependent proatherogenic metabolite TMAO one year after bariatric surgery
Knut Tore Lappegård,
Terje Enebakk,
Hilde Thunhaug,
Anders Hovland
:
Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol
Atherosclerosis 2016 DOI
Torunn Kristin Nestvold,
Erik Waage Nielsen,
Judith K Ludviksen,
Hilde Fure,
Anne Landsem,
Knut Tore Lappegård
:
Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4
Metabolic Syndrome and Related Disorders 2015 DOI
Corinna Lau,
Ståle Nygård,
Hilde Fure,
Ole Kristoffer Olstad,
Marit Holden,
Knut Tore Lappegård
et al.:
CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray
Ingrid Petrikke Olsen,
Ingunn Heggheim,
Knut Tore Lappegård
:
Videreutvikling av desentralisert legeutdanning.Betydning for rekruttering og stabilisering
2023
Bjørn Ove Faldaas,
Erik Waage Nielsen,
Benjamin Stage Storm,
Knut Tore Lappegård,
Ole-Jakob How,
bent aksel nielsen
et al.:
Real Time Feedback of Chest Compressions by Hands-Free Carotid Doppler in a Porcine Model
Circulation 2023
Bjørn Ove Faldaas,
Erik Waage Nielsen,
Benjamin Stage Storm,
Knut Tore Lappegård,
Ole-Jakob How,
Bent Aksel Nilsen
et al.:
RescueDoppler: Non-invasive Handsfree Carotid Doppler Ultrasound For Continuous Hemodynamic-guided Resuscitation
Circulation 2022 DOI
Bjørn Ove Faldaas,
Erik Waage Nielsen,
Benjamin Stage Storm,
Knut Tore Lappegård,
Ole-Jakob How,
Bent Aksel Nilsen
et al.:
Abstract 301: RescueDoppler: Non-invasive Handsfree Carotid Doppler Ultrasound For Continuous Hemodynamic-guided Resuscitation
2020
Synnøve G Mortensen,
Petr Buchmann,
Knut Tore Lappegård
:
Epipericardial Fat Necrosis: A Case Report and a Review of the Literature
Christian Kjellmo,
Gheorghe Pop,
Knut Tore Lappegård,
Anders Wilhelm Hovland
:
Intensive lipid lowering therapy reduces large, but not small, dense low-density lipoprotein particles measured by gel electrophoresis, in elderly patients with atrial fibrillation
European Journal of Preventive Cardiology (EJPC) 2019 DOI
Erik Waage Nielsen,
Knut Tore Lappegård,
Harald Thidemann Johansen
:
Re: Ny og bedre medisin mot hjertesvikt
Tidsskrift for Den norske legeforening (Tidsskriftet) 2015 DOI
The 50 latest publications is shown on this page. See all publications in Cristin here →